ArticleChemphyschem : a European journal of chemical physics and physical chemistry2025
Impact of Replicas and Simulation Length on In Silico Behaviors of a Protein Domain.
Article in Chemphyschem : a European journal of chemical physics and physical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Selection of Novel DNA Aptamers against HPV16 Biomarker, E6: AnACS omega · 2026Article
- Impact of Replicas and Simulation Length on In Silico Behaviors of a Protein Domain.Chemphyschem : a European journal of chemical physics and physical chemistry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Molecular dynamics (MD) simulations are immensely valuable for studying protein structure, function and dynamics. Their ability to capture atomic-level behavior of molecules and describe their evolution over time makes it a powerful synergistic tool for biochemistry, structural biology and other life sciences. To advance research and knowledge on reasonable timescales, researchers must optimize the amount of useful information extracted from simulation data while often frugally managing computational resources. Often, this involves balancing the length of MD trajectories with the number of replicas of a given system, with the aim of maximizing sampling of the conformational landscape. However, identifying this balance is not always intuitive, and the lack of standards among researchers can produce large variability in results and predictions from MD measurements. Here, we investigate the variability in MD results when simulation length and replica numbers are varied. Using a 231-amino acid domain, we compare measurements from independent trajectories to a benchmark trajectory of 3, 1000-ns replicates. We perform these simulations on 27 protein-ligand complexes, allowing us to compare ligand-specific rankings of complexes across independent replicas. Our results reveal that some MD measurements are accurately ranked by single trajectories, while others are not. We uncover similar variability in the effects of trajectory lengths on measurements. Our findings suggest that a one-size-fits-all approach to MD simulations is not necessarily the best approach, and depending on the intended measurements and research question, it may be advantageous sometimes to prioritize longer trajectories over multiple replicas. This work provides important considerations for researchers while designing simulation studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.